The IFNLR1 gene helps cells lining the airways, gut, and other body surfaces respond to interferon lambda, a signal that supports the body’s first defense against viruses. If this gene does not work properly, those surface tissues may have a weaker local antiviral response, which can increase vulnerability to some infections. In medicine, this gene is important because it helps regulate immune activity at barrier tissues without triggering unnecessary widespread inflammation.
What is a gene?
A gene is a section of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the instructions for proteins, which are the working parts of cells. Other genes mainly help manage when certain processes happen, where they happen, and how strongly they operate. Taken together, genes affect how the body grows and works, and they can shape how you respond to food, stress, or medicines. To look into this topic more closely, you can learn more in the LearnHub.
Overview
IFNLR1Gene function
What if the gene works
The IFNLR1 gene helps make a cell surface receptor for interferon lambda. This lets barrier tissues, especially in the airways and gut, switch on antiviral defenses when viruses are present.
Risk
What if the gene does not work
If the IFNLR1 gene works less well, cells respond less effectively to interferon lambda signals, especially at surfaces such as the gut and airways. Milder variants may partly reduce signaling, while more severe variants can greatly limit antiviral gene activation.
Treatment
What does that mean for your treatment
No IFNLR1 specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the IFNLR1 gene. The IFNLR1 pathway is being studied as a drug target in antiviral and gut inflammation research, but this has not led to guideline-based drug choices tied to IFNLR1 variants.
Gene function
What if the gene works
If you carry the IFNLR1 gene, it helps your body mount a focused antiviral defense where germs often first land. Its protein sits on the surface of certain cells and receives interferon lambda messages. Those messages help nearby cells prepare for viral threats, especially along the body’s lining surfaces.
The IFNLR1 gene makes part of a cell surface receiver for interferon lambda, a virus-fighting immune signal. This lets certain cells detect a nearby call to strengthen their defenses.
After receiving that signal, cells switch on genes that help block virus growth and spread. This is a key part of what the IFNLR1 gene does in the immune system.
This pathway is especially active in cells lining the airways, intestines, and other body surfaces. It helps protect the lining of the lungs and gut from viruses while keeping the response more targeted.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IFNLR1 gene can change how much receptor reaches the cell surface, how stably it folds, or how well it passes signals inside the cell. In practical terms, how IFNLR1 gene variants affect protein function often comes down to reduced ligand binding or weaker JAK-STAT signaling (a pathway cells use to relay messages). Some changes are mild and only partly lower signaling, while more disruptive variants can greatly reduce receptor activity or stop signaling altogether.
How variants are linked to conditions
Right now, the IFNLR1 gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. Current evidence on how variants of the IFNLR1 gene are linked to conditions is still evolving, so any reported IFNLR1 variant is best interpreted with your doctor or genetic counselor.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology, and they are widespread in the general population. Most do not have a direct effect on health and instead reflect the natural diversity seen among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors both play a part. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IFNLR1 gene. If a change in IFNLR1 is found on genetic testing, its meaning usually depends on the exact variant and the health issue being looked at.
Inheritance of IFNLR1 variants
There is not yet a broadly confirmed, disease specific inheritance pattern for the IFNLR1 gene, so IFNLR1 gene inheritance is not described in the same clear autosomal dominant or autosomal recessive way used for many well established genetic conditions. The IFNLR1 gene is located on chromosome 1, which is an autosome. This means you inherit one copy from your mother and one copy from your father.
What does my IFNLR1 result mean for my family?
There is not yet a broadly confirmed, condition-specific inheritance pattern for IFNLR1 that is used in routine patient care, though this can become clearer as research develops. If you have a specific IFNLR1 result and want to understand what it could mean for relatives, a doctor or genetic counselor can review your result in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
IFNLR1 genetic testing looks for variants in the IFNLR1 gene using a blood or saliva sample. A lab reads the gene's DNA code, often as part of a multigene panel or exome test, and compares it with a reference sequence to identify changes. Results may show a benign variant, a likely harmful variant, or a finding that needs more interpretation.
When should I consider getting a genetic test?
There isn't yet a broadly established, IFNLR1-specific clinical reason for testing in routine care. Decisions about genetic testing are usually based on your personal health history, symptoms, and family history, ideally with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they reveal depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person and less well for another. These inherited differences are common and can also influence how sensitive someone is to side effects. Medication response is shaped by genes along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes affect responses to medications. It examines links between genes and drugs to help explain why the same treatment can work in different ways for different people. For many medicines, genes influence either how the body processes a drug or how strong its effects are. Knowing this can support treatment choices that are both more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IFNLR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for changes in this gene in guiding medication choices, so questions about treatment, side effects, or medicine interactions are best discussed with your doctor.
History
The IFNLR1 gene entered medical research in the early 2000s, when scientists were identifying a newly recognized branch of the interferon system, a group of signals the body uses during infections. Researchers found that IFNLR1 forms part of the receptor for interferon lambda, helping explain why these signals act strongly at body surfaces such as the airways, liver, and gut. From these first observations, research expanded steadily. This work helped separate interferon lambda signaling from the better known type I interferon pathway and gave scientists a clearer map of how antiviral defenses are organized. Over time, studies of the IFNLR1 gene became especially relevant in infection, inflammation, and liver disease research.